SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-21-000558
Filing Date
2021-02-16
Accepted
2021-02-16 11:21:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT AMENDMENT alyeska-vive123120a1.htm SC 13G/A 103586
  Complete submission text file 0001172661-21-000558.txt   105254
Mailing Address 345 INVERNESS DRIVE SOUTH BUILDING B, SUITE 250 ENGLEWOOD CO 80112
Business Address 345 INVERNESS DRIVE SOUTH BUILDING B, SUITE 250 ENGLEWOOD CO 80112 4085301900
VIVEVE MEDICAL, INC. (Subject) CIK: 0000879682 (see all company filings)

IRS No.: 043153858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42378 | Film No.: 21634370
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601
Business Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601 312-899-7902
Alyeska Investment Group, L.P. (Filed by) CIK: 0001453072 (see all company filings)

IRS No.: 261919051 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A